Jingui Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-5636-6699

发表论文 27 篇 · 总被引 184 次 · h-index 8

代表论文

• Copper( ii ) complexes based on quinoline-derived Schiff-base ligands: synthesis, characterization, HSA/DNA binding ability, and anticancer activity (2018 · MedChemComm · 被引 45)
• Two hydrazone copper( ii ) complexes: synthesis, crystal structure, cytotoxicity, and action mechanism (2016 · RSC Advances · 被引 24)
• Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial (2022 · European Radiology · 被引 17)
• AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression (2023 · Oncogene · 被引 12)
• Improving the Shuffle of Hadoop MapReduce (2013 · 被引 12)
• Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma (2022 · Frontiers in Genetics · 被引 10)